Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial

2016298 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet Neurology

Volume 16, Issue 2, pp. 123-134

Field-Weighted Citation Impact: 22.06